{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:30:30Z","timestamp":1787023830911,"version":"build-2736575974"},"reference-count":0,"publisher":"Sestre Milosrdnice University Hospital Center (KBC Sestre milosrdnice)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ACC"],"published-print":{"date-parts":[[2024]]},"DOI":"10.20471\/acc.2024.63.02.22","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T09:20:32Z","timestamp":1741857632000},"source":"Crossref","is-referenced-by-count":2,"title":["Croatian guidelines for specific preventive treatment of migraine with monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) (eptinezumab, fremanezumab, and galcanezumab) or the CGRP receptor (erenumab)"],"prefix":"10.20471","author":[{"given":"Davor","family":"Jan\u010duljak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8565","container-title":["Acta Clinica Croatica"],"original-title":[],"link":[{"URL":"https:\/\/hrcak.srce.hr\/file\/474344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T17:18:47Z","timestamp":1768238327000},"score":1,"resource":{"primary":{"URL":"https:\/\/hrcak.srce.hr\/clanak\/474344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":0,"URL":"https:\/\/doi.org\/10.20471\/acc.2024.63.02.22","relation":{},"ISSN":["0353-9466"],"issn-type":[{"value":"0353-9466","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}